How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
PET Targeting Acid Phosphatase 3 (ACP3) in Prostate Cancer and Compared With 68Ga-PSMA
Description:
The objective of the study is to construct a noninvasive approach 68Ga-XACP3 PET/CT to detect tumor lesions in patients with prostate cancer and to compare with 68Ga-PSMA PET/CT.
Contacts:
Liang Zhaowzhaoliang01@163.com
86 18818350620
Haojun Chen, MD, PhDleochen0821@foxmail.com
86 18659285282
Government Study Link:
NCT07242014 - Click here to see study onClinicalTrials.gov
68Ga-XACP3
Isotope(s):
Target(s):
- Acid Phosphatase 3 (ACP3)
Ligand: Small Molecules
Chelator: DOTA
